New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.
JCI Insight
; 5(14)2020 07 23.
Article
in English
| MEDLINE | ID: covidwho-768184
ABSTRACT
Purinergic signaling is discussed as a potential therapeutic target to reduced COVID-19 severity.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Thrombosis
/
Coronavirus Infections
/
Dipyridamole
/
Purinergic Agents
/
Cytokine Release Syndrome
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
JCI.INSIGHT.140971
Similar
MEDLINE
...
LILACS
LIS